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Abstract The 14-3-3 protein family binds a variety of proteins 
in cell-signaling pathways, but the structural elements necessary 
for the ligand binding are poorly understood. Here we 
demonstrate that the 'box-1' region, which spans residues 171— 
213 in the T|-isoform and was previously identified as the binding 
site of 14-3-3 to the phosphorylated tryptophan hydroxylase, 
plays a critical role in the interaction with many target proteins. 
Using a series of truncated 14-3-3 mutants, we show that the 
mutant 167-213 carrying box-1 binds bacurovirus-expressed 
Raf-1 and Bcr protein kinases to the similar extent as the full-
length 14-3-3 in a phosphorylation-dependent manner, while the 
mutants lacking this region abolish the binding activity. 
Furthermore, the box-1 region also appears essential for binding 
of 14-3-3 to more than 40 phosphoproteins found in the brainstem 
extract. These results suggest that the box-1 region, consisting of 
helices 7 and 8 in the tertiary structure, is a common structural 
element whereby the 14-3-3 protein binds many, if not all, target 
proteins. 
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1. Introduction 
The 14-3-3 protein is a family of acidic, dimeric proteins 
with a relative molecular mass of ~ 60 k D a distributed widely 
among eukaryotic cells. This protein family binds a variety of 
proteins in intracellular signaling pathways and participates in 
the regulation of cell proliferation, differentiation, and func-
tions (reviewed in [1] and [2]). Although the precise role of this 
family is not fully elucidated at a molecular level, its binding 
specificity is beginning to emerge from recent studies. It has 
been shown that the interaction of 14-3-3 with tyrosine (TH) 
and t ryptophan hydroxylases (TPH) depends on the phos-
phorylation of these hydroxylases with calmodulin (CaM)-de-
pendent protein kinase [3-5], and likewise, the complex of 
14-3-3 with Raf-1 and with Bcr protein kinases dissociates 
by phosphatase treatment [6]. Furthermore, analysis of the 
primary site of phosphorylation in Raf has led to the identi-
fication of a 14-3-3 binding sequence, RSxS(j?)xP, where S(/>) 
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is phosphoserine [7]. These results suggest that phosphoryla-
tion of the target protein at a single serine residue triggers 
14-3-3 binding. 
On the other hand, little is known about the region(s) of 
14-3-3 responsible for target binding. We have previously 
shown, using a series of truncation mutants of the 14-3-3 
r|-isoform expressed in Escherichia coli, that the COOH-ter-
minal region, especially restricted in residues 171-213 (termed 
box 1), is essential and sufficient for the association of 14-3-3 
with phosphorylated T P H [8]. F rom this result, together with 
the general phosphorylation-dependent mechanism of the 
14-3-3/ligand interaction, we assumed that box-1 might also 
be a site of interaction with other target proteins [8]. In this 
study we have examined this assumption and demonstrate 
that box-1 indeed acts as a common binding site of 14-3-3 
for many target proteins including Raf-1, Bcr, and brainstem 
phosphoproteins. 
2. Materials and methods 
2.1. Plasmid constructions 
The cDNAs for the full-length glutathione-S-transferase (GST)-14-
3-3 n and its truncation forms were generated by a PCR, and ligated 
into the cloning site of the bacterial expression vector pGEX-3X 
(Pharmacia Biotech Inc.) as described [8]. The full-length cDNA for 
human Raf-1 [9] was synthesized by a PCR using oligonucleotides 
(5'-TGGATCCCAATGGAGCACATACAGG-3' and 5'-AGAATT-
CCTAGAAGACAGGCAGC-3'). The PCR fragment was digested 
with BamHl and EcoRl and the EcoRl site was blunted with Klenow. 
Then the PCR fragment was inserted into the BamHl and Hindlll 
sites (where the Hindlll site was blunted) of bacurovirus expression 
vector pBlueBacHisC (Invitrogen). Bcr cDNA was made by cleaving 
the plasmid pGD'210 [10] with iico52I and Bglll followed by blunting 
both sides with Klenow. The cDNA fragment was cloned into the 
blunted BamHl and Hindlll sites of pBlueBacHisC. The resulting 
cDNA encodes the region of first exon Bcr kinase (amino acids 
1—412) which contains the intrinsic 14-3-3 binding site [11]. 
2.2. Expression and purification of proteins 
GST fusion proteins were expressed in Escherichia coli strain JM109 
and purified on glutathione-Sepharose 4B beads (Pharmacia Biotech 
Inc.) as described [8]. Raf-1 and Bcr protein kinases were expressed in 
Sf21 insect cells and purified on Ni-NTA agarose beads (Qiagen) 
according to the procedure provided by the supplier. 
2.3. Binding assay 
Raf-1 or Bcr protein (~0.1 ug each) was incubated for 20 min at 
30°C with appropriate amounts of GST-fusion proteins (see figure 
legends) in a buffer containing 25 mM HEPES, pH 7.4, 10 mM 
MgCl2, 10 mM MnCl2, and 0.5 mM ATP (for Raf-1) or containing 
20 mM HEPES, pH 7.4, 20 mM MnCl2, and 0.5 mM ATP (for Bcr) 
in a final volume of 200 ul. Glutathione-Sepharose beads ( ~ 50 ul) 
that had previously been incubated in 5% (w/v) skim milk were then 
added to the mixture and incubated for 60 min at 4°C. The protein 
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complexes bound to the beads were washed 3 times with 500 ul of 
20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM dithiothreitol 
and solubilized in a SDS-sample buffer. The bound Raf-1 and Bcr 
were analyzed by SDS-PAGE followed by Western blotting using an 
antibody to each protein kinase (Santa Cruz Biotechnology). The 
binding assay was also performed with the rat brainstem extract. In 
this experiment, the extract previously fractionated with 25-55% sat-
urated (NH4)2S04 (500 ug protein) was incubated at 30°C for 20 min 
in a buffer (200 ui) containing 50 mM HEPES, pH 7.6, 5 mM 
Mg(CH3COO)2, 0.1 mM CaCl2, 0.05 mM ATP, 10 itCi [y-
32P]ATP 
(Amersham Corp.), 4 u,g of CaM [9] and 5 (tg of GST-fusion proteins. 
After GST-fusion protein was recovered as described above, the 
y-32P-labeled proteins bound to the fusion protein were analyzed by 
autoradiography following 2D-PAGE [12]. 
2.4. Others 
Phosphatase treatment was performed essentially according to the 
procedure described in [6]. Briefly, Raf-1 or Bcr protein (~0.1 ug 
each) was incubated for 20 min at 30°C with or without 3 U of 
type VII potato acid phosphatase (Sigma) in a buffer containing 
40 mM PIPES, pH 6.0, 10 mM MgCl2, and 10 mM MnCl2 (for 
Raf-1) or in a buffer containing 40 mM PIPES, pH 6.0, and 20 mM 
MnCl2 (for Bcr) in a final volume of 200 ul The amounts of recombi-
nant proteins were evaluated from the densitometric quantitation of 
the protein bands after SDS-PAGE and Coomassie Blue staining. 
3. Results 
A series of COOH-terminal truncation mutants of the 
14-3-3 T|-isoform expressed as the GST-fusion proteins (illus-
trated in Fig. 1A) were examined for their binding activities to 
Raf-1 and Bcr protein kinases. Raf-1 or Bcr was incubated 
with the truncated GST-fusion proteins and glutathione-
Sepharose beads were added to the mixture to collect the 
fusion mutants. Raf-1 or Bcr bound to the mutants was 
then assayed by Western blot with a specific antibody to 
each protein kinase. This analysis revealed that the deletion 
mutants carrying the box-1 region (mutants 1-237 and 1-213) 
bound these protein kinases, while the mutants lacking box-1 
(mutants 1-78 and 1-170) did not (Fig. IB). This suggests that 
box-1 is involved in the Raf/Bcr binding. 
To confirm the above observation, similar experiments were 
performed using two additional mutants (167-213 carrying 
box-1 and A171-213 lacking box-1; see Fig. 1A). This analysis 
proved that box-1 is the primary site for interaction of the 
n-isoform with Raf-1 and Bcr, because the mutant 167-213 
bound these proteins to the similar extent to the full-length 
r)-protein (compare Fig. 2A, lanes 1 and 3) and the deletion 
mutant lacking 171-213 (A box-1) bound neither Raf-1 nor 
Bcr (lane 2). 
Since the complex formation between 14-3-3 and Raf-1 and 
between 14-3-3 and Bcr had been shown to be prevented by 
the treatment of these kinases with protein phosphatase [6], 
we examined whether the mutant 167-213 binds the phospha-
tase-treated Raf-1 and Bcr. As shown in Fig. 2B, the binding 
of Raf-1 or Bcr to the T|-protein (lanes 1 and 2) as well as to 
the mutant 167-213 (lanes 3 and 4) was apparently inhibited 
by the phosphatase treatment. After phosphatase treatment, 
both Raf-1 and Bcr exhibited slight mobility shifts on SDS-
PAGE (see Fig. 2B, lower panel), probably due to the removal 
of phosphate from the bacurovirus-expressed proteins. Thus, 
like the full-length 14-3-3 proteins, interaction between box-1 
and the target proteins is phosphorylation-dependent. 
Although the n-protein was identified to be an isoform that 
bound preferentially Raf in 293T cells [13], other isoforms 
such as (3 and C, also bind Raf in vivo [14] and in vitro [7]. 
We have prepared the mutants with and without box-1 on the 
basis of the P sequence and demonstrated that this isoform 
also requires the box-1 (166-208 in the P sequence) for Raf 
binding (Ichimura et al., unpublished results). Likewise, the 
mutants carrying box-1 (residues 166-208) of the x-isoform, a 
rat counterpart of mouse Bcr-binding protein Bap-1 [11], 
bound Bcr, while the mutants lacking box-1 did not. 
To further evaluate the box-1 function in the 14-3-3/ligand 
interaction, we performed the following experiment. A crude 
extract was prepared from the rat brainstem, and to the ex-
tract was added the full-length ti-protein or the mutant Abox-
1 fused to GST. After the mixture was incubated in the pres-
ence of Ca2+, CaM and [y-32P]ATP, the GST-protein was 
precipitated with glutathione-Sepharose and the co-precipi-
tated y-32P-labeled proteins were analyzed by autoradiography 
following 2D-PAGE (Fig. 3). From the extract supplemented 
with the full-length T|-protein more than 40 phosphoproteins 
were co-precipitated, while a few were detected with the mu-
tant Abox-1 (Fig. 3, compare A and B). In addition, most of 
the phosphoproteins co-precipitated with the mutant Abox-1 
Fig. 1. Deletion analysis of the functional region of 14-3-3 n. A: Schematic illustration of wild-type and mutant forms of 14-3-3 n. For simplic-
ity, only 14-3-3 regions of the fusion proteins are shown. For wild-type 14-3-3, the box-1 region is indicated by a hatched box. For mutants, 
dotted lines are used to depict the regions in the n sequence, where the numbers indicate the residue numbers of NH2 and COOH termini of 
each mutant. B: Binding of the deletion mutants to Raf-1 and Bcr. Raf-1 or Bcr (~0.1 ug each) was incubated with 25 pmol of each protein 
and processed as described in Section 2. Raf-1 or Bcr bound to the fusion protein was detected by the immunoperoxidase-ECL (Amersham 
Corp.). 
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Fig. 2. A: Binding of mutants 167-213 (vboxl) and A171-213 (vAboxI) to Raf-1 and Bcr. Raf-1 or Bcr (~0.1 |xg each) was incubated with 
40 pmol of each protein and analyzed as in Fig. IB. B: Effect of phosphatase treatment. Raf-1 or Bcr (~0.1 ug each) was incubated with (+) 
or without (—) potato acid phosphatase for 20 min and examined for binding to the full-length r\ or to the mutant 167-213 (vboxl) (upper 
panel). After phosphatase treatment, an aliquot of the reaction mixture was examined by Western blotting (lower panel) to exclude the possibil-
ity of proteolytic cleavage during the reaction. 
appeared to result from non-specific binding to the GST moi-
ety of the fusion protein (data not shown). Although most of 
the phosphoproteins associated with the GST-T)-protein were 
not identified in the present study, we detected TPH as one of 
those proteins by Western blotting (indicated by an arrow in 
Fig. 3). Therefore, the box-1 region appears to be a site of 
interaction in 14-3-3 for a variety of proteins including TPH, 
Raf-1, Bcr, TH (Ichimura et al., unpublished results), and 
many potential target proteins in the brainstem extract. 
4. Discussion 
In this study we have shown that box-1 represents a com-
mon structural element of the 14-3-3 protein for its ligand 
binding. This region consists of helices 7 and 8 located near 
the edge of the groove-like tertiary structure, and has an ami-
no acid sequence which is highly conservative among the 
members of the 14-3-3 family found in yeast to man [8]. 
This may explain why several mammalian 14-3-3 isoforms 
bind in vitro to human Raf-1 and Bcr protein kinases 
([8,11], and data not shown) and the yeast 14-3-3 proteins 
activate the human Raf-1 kinase [9]. Recent findings, however, 
show that some isoforms of this family have different affinities 
to several target proteins, suggesting an isoform-specific lig-
and binding. For example, A20, an inhibitor of tumor ne-
crosis factor-induced apoptosis, was bound preferentially to 
Fig. 3. Two-dimensional analysis of brainstem phosphoproteins bound to the full-length 14-3-3 (A) and the mutant A171-213 (B) fused to 
GST. The rat brainstem extract (500 ug protein) supplemented with 5 ug of each protein was phosphorylated as described in Section 2, and 
the phosphorylated y-32P-labeled proteins bound to each fusion protein were analyzed by autoradiography after 2D-PAGE. TPH (indicated by 
an arrow) was identified by Western blotting with an antibody to TPH [8]. 
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the endogenous r|-isoform when A20 was transfected into 
293T cells [13]. The |3- and ^-isoforms bound A20 much 
weakly, and the e-isoform had an intermediate affinity. It 
has also been shown that the n-isoform binds preferentially 
Raf-1 in 293T cells [13]. It is possible, therefore, that the 
variation in a few amino acids within the structure of box-1 
or an additional region to box-1 may determine the isoform 
specificity in the 14-3-3/ligand interaction. However, we were 
not able to detect the isoform-specific interaction in the 
present assay performed. 
Recently, a consensus sequence motif, RSxS(/>)xP, has been 
proposed for the sequence that binds 14-3-3 [7]. In fact, the 
synthetic peptide containing this motif binds 14-3-3 in a phos-
phoserine-dependent manner, disrupts the 14-3-3/Raf com-
plex, and inhibits the maturation of Xenopus laevis oocyte. 
It has also been shown that this motif is found in common 
with many 14-3-3 target proteins including Bcr, two apopto-
sis-related proteins A20 [13] and Bad [15], and plant nitrate 
reductase [16]. The present study demonstrates that box-1 is a 
site of interaction with Raf/Bcr kinases and that the interac-
tion is dependent on phosphorylation (Fig. 2). However, 
whether the box-1 structure directly recognizes the binding 
motif remains to be established. Further studies are also 
needed to specify residues, within box-1, which are directly 
involved in the ligand binding. Such a study will facilitate 
the analysis of the 14-3-3/ligand interaction at a tertiary struc-
ture level and aid studies of the 14-3-3 function, for instance 
by assisting a design of drugs that modulate 14-3-3-mediated 
intracellular signaling. 
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